Search
for
Sort by
Research 541–570 of 1000+
- Synthesis and biological evaluation of esters of 16-formyl-17-methoxy-dehydroepiandrosterone derivatives as inhibitors of 5α-reductase type 2
- Metformin and malignant neoplasms: a possible mechanism of antitumor action and prospects for use in practice
- Targeting the Warburg Effect in Anaplastic Thyroid Carcinoma: Metabolic Vulnerabilities and Therapeutic Opportunities
- Repurposing Auranofin for Oncology and Beyond: A Brief Overview of Clinical Trials as Mono- and Combination Therapy
- Chemistry, Pharmacology and Therapeutic Potential of Decursin: A Promising Natural Lead for New Drug Discovery and Development
- Alternative androgen pathways
- Biological therapy in the treatment of melanoma
- PROTACs in 2025: from the laboratory concept to clinical breakthrough
- Spotlight commentary: Navigating the cutaneous side effects of chemotherapy
- Synthesis and application of clinically approved small-molecule drugs targeting androgen receptor
- In silico structural prediction of human steroid 5α-reductase type II
- Mendelian randomization studies of testosterone exposure: A systematic review
- A comparison of self-reported signs of facial aging among women in Australia vs. those in the United States, United Kingdom, and Canada
- The JAK/STAT signaling pathway: from bench to clinic
- Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities
- Current evidence for the involvement of sex steroid receptors and sex hormones in benign prostatic hyperplasia
- A Concise Review of Organoid Tissue Engineering: Regenerative Applications and Precision Medicine
- RAGE and Its Ligands in Melanoma
- Translating Resveratrol Research: A Systematic Review on Patents and Clinical Trials (2000–2025)
- Peptide-Based PROTACs: Transitioning from Static Paradigm to a Dynamic Landscape within Targeted Protein Degradation
- Estrogen and androgen signaling in the pathogenesis of BPH
- 5alpha-reductase: history and clinical importance.
- The role of mutations on gene AR, in androgenetic alopecia syndrome
- 5 alpha-reductase inhibition by a new synthetic steroid (PM-9) in cultures of Penicillium crustosum.
- Pharmacological Role and Clinical Applications of 5α-Reductase Inhibitors-Review Article for Pharmacists and Healthcare Professionals
- Six Novel Susceptibility Loci for Early-Onset Androgenetic Alopecia and Their Unexpected Association with Common Diseases
- Therapeutic Potential of Brassinosteroids in Biomedical and Clinical Research
- Valorization of Punica granatum L. Leaves Extracts as a Source of Bioactive Molecules
- Turmeric Essential Oil Constituents as Potential Drug Candidates: A Comprehensive Overview of Their Individual Bioactivities
- Evolving CRBN ligands enhance the drug-like properties of protein degraders